Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Aarti, Adcirca, Aetna, agonist, Agri, AIA, AMP, AOCL, arbitration, arose, Arzneimittel, ASC, assimilate, Assimilation, ASU, Augusta, Avid, Baker, Barnett, Bipartisan, BIVIP, BIVIVP, bolster, BPCI, broiler, chicken, Christensen, compatible, compliant, conspiracy, contest, corrective, CureVac, curtailment, Daniel, deploy, disproportionate, Dodge, Dual, Eagle, error, exploitation, exploring, Florida, Fort, founder, fraud, fundamentally, Galliprant, gather, Georgia, GILTI, hardware, hookworm, Hurricane, installment, interference, Iowa, Johna, Joshua, KeyBioscience, lanabecestat, Ltda, merger, metabolic, Microsoft, middle, Minnesota, Mississippi, misused, MSP, narrative, Nektar, Nipro, Norton, obsolescence, owed, PCAOB, pertinent, Pharm, plaintiff, provisional, Pusey, Quimica, Rabvac, Radiopharmaceutical, rbST, reclassification, refile, regime, remeasurement, remeasuring, rendered, Restated, Resubmitted, retention, retroactive, RNActive, roundworm, rulemaking, scheme, Shah, Shaw, shut, Skovronsky, Smiley, Stada, Strafford, stranded, Streck, succeeded, superseded, surfaced, tapeworm, temporarily, Toll, unsealed, Verzenio, VerzenioTM, Washington, whipworm, withholding, XR
Removed:
Abbott, absence, Allergan, amendment, API, applicator, apportioned, attention, awarded, Barton, bound, chairman, choose, close, Crowe, Cuxhaven, Derica, evacetrapib, extra, FASB, finance, Fionnuala, granting, headquartered, Immunocore, indemnify, issue, Ixekizumab, John, leader, Lechleiter, lodged, Lohmann, Louisiana, Necitumumab, neutralizing, operational, opposition, PCI, peglispro, Peterson, ratio, remained, remitted, repaid, repatriated, Rice, Saavedra, Sandoz, SE, Shionogi, subsequently, supporting, taxed, topical, underarm, variability, Walsh
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Eli Lilly and Company Performance Award (for Executive Officers)
- 10.3 Exhibit 10.3
- 12 Statement Re: Computation of Ratio of Earnings (Loss) to Fixed Charges
- 21 List of Subsidiaries and Affiliates
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of David A. Ricks, President & Chief Executive Offi
- 31.2 Rule 13A-14(A) Certification of Derica W. Rice, Executive Vice President, Global
- 32 Section 1350 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated LLY transcripts
LLY similar filings
Filing view
External links